News items related to: Opinion
-
A look into the findings of the Market Intelligence Study for Uganda
In full recognition of the gloom that hovers around the withdrawal of funds, allow me shed a little light to...
-
COVID-19 – entering year three of normalizing profit over life
March 2022 marked the beginning of the third year of the COVID-19 pandemic. The status quo hasn’t changed: as pharmaceutical...
-
COVID-19 Pandemic: Bolsonaro and the Pharmaceutical Industry Are United Against Access to Medicines in Brazil
A new chapter of Bolsonaro’s deliberate strategy to spread the coronavirus has begun. This time, his government is partnering with...
-
Pharma continues to lie about the necessity of vaccine patents – don’t be fooled
It’s an interesting time for intellectual property (IP) rights. Last week, we here in the UK watched with more than...
-
Why my vaccine doesn’t reassure me
I received my first COVID-19 vaccine last week. I’m 42, with no known underlying health conditions, and I’m not a...
-
COVID-19: While richer countries talk, the poorest of us are left behind
This month – coinciding with World Vaccination Week and World Intellectual Property (IP) Day – behind closed doors, members of...
-
“Training the next generation of treatment activists in Central America”
“Only around half of people living with HIV across Central America have access to life-saving treatment. The picture when it...
-
OPINION: Breaking a ‘vicious cycle’ of overpaying for HIV drugs in Ukraine
“In November 2020, Ukraine finally shifted from the overpriced branded version of darunavir (DRV) to the more affordable generic version of...
-
HIV activists are essential to the COVID-19 response
The legacy of HIV activism is approaching a 40-year history, one which is inextricably linked with the actions of pharmaceutical...
-
COVID-19 & TB: Why whether you live or die is a matter of justice, not science
Johnson & Johnson, a brand built on images of happy gurgling babies and the tagline ‘no more tears’, has the...
-
New money for old drugs: COVID-19 is not a profit-making opportunity
To try to limit the catastrophic impact of COVID-19, a huge amount of funding has been invested into scientific development...
-
Indonesia: Community action results in cheaper HIV treatment
First published by The Jakarta Post. Indonesia has an increasing rate of new HIV infections, with approximately 46,000 people newly...
